THE CHRONOLOGY OF
THE CRIME
--Paul
Ehrlich and Compound 606,
Syphilis, salvarsan (arsenical)
http://www.whonamedit.com/doctor.cfm/83.html
--1911,
Andrew Balfour, MD, Karoum,
"Infective
granules" Read- He talks about intracellular
spirochetes
--1932
Report (Relapsing Fever, to
be scanned)
--1932
Tuskegee "Bad Blood" (Typical CDC Handiwork)
http://www.whale.to/p/tuskagee.htm
--1944
Relapsing
Fever Borrelia, Lancet, RAMC, WWII,
Lybia, Borreliosis is incurable
--
1951:
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=386134&blobtype=pdf
:



-- 1963:
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=277165&blobtype=pdf

US scientists discussing spheroplast forms (click to enlarge)
-- 1965
http://mmbr.asm.org/cgi/reprint/29/1/46?view=long&pmid=14295985
Felsenfeld, Comprehensive Review of the status of the Genus Borreliae,
1965
--1975,
Polly Murray finally gets someone's attention. (It's a bad accident, Draft
Dodger, CDC EIS Officer, Steere.)
--1976
Borreliois is
an incurable brain infection. US Military Hosp, Bethesda, MD:
Borrelia persist in the brain past
treatment
States in this book
that 1/6 to 1/3 of all Lyme patients are permanently neurologically impaired,
in neurosyphilis: http://www.emedicine.com/neuro/topic684.htm
--1982,
Willy Burgdorfer: Discovers the
spirochete
and discusses cyst or spheroplast or starvation forms
Abstract, MEDLINE
--1980 to 1983,
Edward Eisenberg, OXFORD insurance company, is an NIH clinical researcher in
infectious diseases. 'Stated at the Blumenthal Lyme Hearing in 1999 that
the testing for Lyme is as accurate as the testing for any other infectious
disease
--1983,
Proposed Life Cycle for the Reiter
Treponeme (validity of
"cysts", or spheroplasts. or
regeneration forms)
-- 1986,
McSweegan trashes the Navy to give all the grants to his buddies,
like Yale's Durland Fish
--1986,
Steere, The Original Serodiagnosis, later falsified :
Here
-- 1986
Alan Barbour
publishes his comprehensive article on Borrelia. Mentions rodent brains as
the storage media.
http://mmbr.asm.org/cgi/reprint/50/4/381?view=long&pmid=3540570
--1988, Lyme
Foundation Founded,
http://www.lyme.org
--1988, Russell C. Johnson,
First vaccine patent: US Patent
4,721,617
Borreliosis is incurable
Chronic Treatment for chronic infection.
-- 1989,
Infectious Disease Reviews,
TRUTH (therefore, remains, the
Truth)
--1989,
Benach, Early Central Nervous System
Invasion
-- 1990, CDC Adopts
Allen Steere's method for diagnosing Lyme as a relapsing
fever borreliosis, by performing serial Western Blots to look for changing and
expanding IgM and IgG antibodies, since the production of NEW IgM means the
bug is still alive and not killed by antibiotics.
This criteria is later changed at the fake
Dearborn consensus conference, which was designed around changing Lyme into an
untreatable autoimmune arthritis in a knee.
--1990,
http://www.ALDF.com ALDF.com founded. Is a "front" or
a false non-profit, since they publish bogus articles
ALDF BOARD OF
DIRECTORS, 1999 Insider Investors and Israeli insider bioweaponeers,
Hank Greenberg, Mortimer Zuckerman, and now
www.otaotr.com which is an international, illegal Jewish spying firm.
--1990, Sigal
begins his Spin at Robert Wood Johnson
Abstract, MEDLINE
--1990-1992,
LymeRIX coming along (Fikrig, animal studies; LYMErix fails to prevent Lyme)
--1990,
John Connolly, Gary Wormser, and Durland Fish decide to capitalize on
Tick Borne Infections and control
treatment and outcome of them (ALDF.com was born). Establish the
"entrepreneurial trio."
--1991,
Steere, sorta doing fine before the BrainWobble...
http://www.geocities.com/kmdickson0308/1-6.txt
-- 1992
Steere at the
"Academy
of Insurance Medicine"
--1992,
Formation of Multiple Treponemes
--1992,
Formation of
http://www.CastleConnolly.com By
KAISER and John Connolly to limit
Managed Care's payment for treatment
with ceftriaxone. 1989 Infectious
Disease Reviews, Dattwyler:
Treatment remains speculative.
--1992, 1993:
Steere has a major BrAiNwArP (Same time as Steere in Europe) >> Lyme is
actually FM, CFIDS, and Hypochondria?
Don'tchya hate it when that happens?
The man thought he discovered a disease,
and he didn't after all? (He used
strain G39/40, which detects Lyme
disease 14% of the time, according to
Imugen's submission to Dearborn).
Note that
CastleConnolly and Steere having a
brainwarp occur at the same time.
Steere, 1991: Lyme is "perilously
close to FM, CFIDS, and Depression."
1992,
Spirochetes suddenly start cooperating
with Managed Care after millions of
years of evolution.
Steere BrainWarp Abstract A:
Abstract, MEDLINE
Steere BrainWarp Abstract B:
Abstract, MEDLINE
1992-
Steere goes to Europe
with a
"bogus" borrelia, one that is "high
passage" (which is illegal):
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=810676
1992-
Cold Spring
Harbor labs hold a conference. Duray, Sigal, Dattwyler.
Dattwyler says, expanding IgM and IgG
demonstrates the persistence of the
illness. (However, antibodies to
just lipoproteins are not the only
antibodies-- There are antibodies to
other membrane components, such as: New
marker:
http://www.jbc.org/cgi/reprint/M305799200v1.pdf
GLYCOLIPID-- Neuroborreliosis and Not
LymeRIX disease. Structure seen on
page 34 of the .pdf GC-MassSpec)
See Pathologies Anti-glycolipid
antibodies
1993,
Joe Burrascano complains to Congress.
Nothing is done because
Dodd and Kennedy know Plum Island is a
bioweaponeering facility and don't actually care about their
constituents, since the self-jerking off "military men are dumb, stupid
animals to be used as pawns for foreign policy"-- Heiney Kissinger.
--1993,
The
Dreaded Dressler/Steere Report:
MEDLINE,
Full Text
leaves OspA and B out of the standard,
because they used a high passage strain,
which dropped expression of OspA and B.
Additionally, in the prospective study,
only late Lyme arthritis have this
presentation at 72%.
Dressler/Steere does not agree at all
with Steere's first serodiagnosis
criteria.
--1993,
Fikrig Yale:
OspA Suppresses the immune response in Mice
MEDLINE
--1993,
Fish and Barbour begin the spin. Barbour, re OspA "we don't know what it
does" (Re: the OspA)
MEDLINE "The biological and
social phenomenon of Lyme disease."
(Now Lyme is a Character Flaw.)
Phase II Vaccine trials underway.
Barbour's hometown wants to erect a
statue of him.
--1994, MARCH,
Connaught Vaccine trial
begins (where did the standard come
from?? Dearborn hadn't happened
yet..)
Later Lenny Sigal, who headed the Connaught
ImmuLyme trial, reported that he could not read his Western Blots using
MarDx test strips, in a report with Molloy and Persing. So, although
Sigal reported that ImmuLyme was 92% effective at preventing Lyme, he later
said the Western Blots were unreadable, and that he could not really tell if
ImmuLyme prevented Lyme, neglecting to mention that LYMErix and ImmuLyme
used the same MarDx test strips to assay vaccine outcomes.
The Sigal ImmuLyme report where he says
ImmuLyme is 92% effective and that he was using MarDx Blot strips:
http://content.nejm.org/cgi/content/abstract/339/4/216
(New England Journal of BigInsurance Propaganda and BigPharma Disease
Mongering)
http://content.nejm.org/cgi/content/full/339/4/216 full text
"A total of 10,305 subjects (age range,
18 to 92 years of age) were enrolled at 14 study sites in areas
of the United States in which Lyme disease was endemic and were
randomly assigned to receive two doses of either 30 µg of OspA
vaccine or placebo, given one month apart, according to a preset
randomization schedule. Randomization was balanced at each study
center in treatment blocks of 10. The first injection was given
between March 1, 1994, and April 30, 1994, [BEFORE
THE DEARBORN CONFERENCE, WHICH TOOK
PLACE IN OCTOBER 1994, SO WE WONDER WHO SAID THEY COULD USE THE BOGUS
DRESSLER/STEERE CRITERIA TO ASSESS OUTCOMES???] and the second
injection was given approximately one month later, between April
1, 1994, and May 31, 1994. At the request of the Food and Drug
Administration, we obtained data on a third dose of vaccine given
12 months after the first injection. A total of 7515 subjects
received a third (booster) injection of placebo or vaccine
between March 1, 1995, and April 30, 1995. The subjects were
observed during the two seasons in which the risk of disease
transmission was greatest, irrespective of whether they had
received the booster dose.
"Subjects in whom Lyme disease was
suspected returned to the study center, where a clinical
evaluation was performed by the investigator and serum samples
were obtained during the acute and convalescent phases of the
illness. Western blot analyses (MarDx Western blot kit, MarDx
Diagnostics, Carlsbad, Calif.) to determine whether IgG or
IgM antibodies to B. burgdorferi were present were performed for
all subjects with suspected cases of Lyme disease by the central
laboratory (Division of Infectious Diseases, New York Medical
College, Valhalla), according to the manufacturer's instructions.
Results were considered positive if the serum sample contained
IgM antibodies that reacted with at least 2 of the following 3
bands: 25 kd (corresponding to band 23, which indicates OspC), 39
kd, and 41 kd within the first 60 days after the onset of
erythema migrans, symptoms, or both or with IgG to at least 5 of
the following 10 bands: 21, 25 (23), 28, 30, 39, 41, 45, 58, 66,
and 83 (corresponding to band 93) kd at any time after the onset
of symptoms. The reports of the results of these tests were sent
to the investigators and did not include specific information on
reactivity to OspA bands.
The Sigal-Persing Molloy Unreadable Blots
report:
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920
Everyone in the world ought to read this full text report, because it seems
like what I told the FDA Vaccine
Committee was more true than I even knew at the time about LYMErix
appearing to activate latent infection in people who had Lyme previously and
believed they had recovered.. I was just observing the empirical data (the
victims of LYMErix called me, very ill, looking for help)
BLOT SMUDGING-- Unreadable blots in OspA vaccinated people, alleviated by
using a strain of Bb with no OspA-B plasmid in it. Here Persing is talking
about LYMErix, when in fact, his co-author, Lenny Sigal ran the ImmuLyme
trial, did not report blot smudging, and Persing already knew about the blot
smudging since that's the RICO patent that Persing developed with Schoen and
the reason OspA and B were left out of the diagnostic standard!! See 1)
above for the journal report that goes with the Persing RICO patent:
?????????????????

Unreadable blots graphics.
--1994 JUNE Vaccine Meeting Minutes:
Dattwyler and Luft, 2/3 of EM patients
have Bb DNA in their CSF,
Dattwyler *says* use serial
Western Blots to assess outcomes. This is ignored.
--1994,
Steere and Long Term Outomes:
http://www.acponline.org/journals/annals/15oct94/lyme.htm
--1994, OCTOBER,
The CDC's
Dearborn FARCE
MORE
HERE, in Chapter 3 of the Cryme Disease
book.
--1995, Shapiro
(Shapiro and Sigal = "The Twins" Spindoctors-- NOT TRUE →
"Lyme
in Children"
--1998 FDA
Vaccine Meeting Minutes...
http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3422t1.rtf
--1998 LymeRIX "results"
MEDLINE
--1998,
December, LYMErix "approved" by the FDA.
--1999,
February, Blumenthal Hearing:
http://www.cslib.org/attygenl/health/lyme.htm
--1999,
Summer:
ACTIONLYME founded. We Support Group Leaders started receiving phone
calls from patients who had Lyme "again." They had received the vaccine.
I called Dennis Parenti at SmithKline in Philadelphis and visited Karen Forschner of the Lyme Foundation...
ActionLyme History
-- 2000
Reporting
Robert Schoen to the CT Medical Board.
--2000, March, Vijay Sikand, East Lyme, CT:
Not reporting
adverse events, East Lyme, CT, USA,
March 10, 1999, "New London Day",
Letter to the Editor
--Letters to Holc
Noble and the New York Times: May, 2000, The Times
--2000 December
NY DOH OPMC
CORRUPTION, December, 2000
This report later
becomes "Pat Smith's Big Books," when it was re-written and
added to by Pam Weintraub. Art Doherty summarized grants for me.
--2001, January 31,
FDA Vaccine Meeting: Chronic Disability, and 4/13 spontaneous abortions
(miscarriages) from rOspA (LymeRIX):
http://www.fda.gov/ohrms/dockets/ac/cber01.htm#Vaccines%20&%20Related%20Biological
3680t2.rtf (1/31/2001)
(January
2001 FDA LymeRIX Vaccine Meeting Minutes
4/13 miscarriages-extra copy)
".....as soon as
Asymptomatically infected individuals
got the vaccine, they (became ill) moved
into the "Unconfirmed Lyme" group.
The vaccine did not "Prevent
Asymptomatic Infection" as SmithKline
claimed. It just made people
sick." See: BARBOUR
LOBET
(SMITHKLINE):
"The absence of
B. burgdorferi in " Treatment Resistant
Lyme Arthritis" joint is still debated"
--Spontaneous Abortions? 'Perhaps
shedding some light on undetected Lyme
and associated infections on the fact of
CT having the highest rate of Attention
Deficit Disorder in the country, and the
Epidemic of
Behavorial Disorders in Young Children
in CT.
Maternal antibodies and Learning
Disorders, e.g., Lupus
See
also, Steere's report
Here, on
maternal borreliosis infection and the
fetus, and his report on Anticardiolipin
antibodies:
Here
And
which also asks, is there an increase in
the number of miscarriages,
corresponding to the epidemic of
neurodevelopmental problems in the USA
and Europe?
May and June, highest rate.
"The
results suggest that maternal immune
system products can modulate the immune
response of the offspring."
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8736093&dopt=Abstract
2001 --"Klempnerized"
(again), July 12, 2001, NEJM,
ILADS Rebuttal to
July 12, 2001 NEJM, Klempner's Chronic
Lyme "long term treatment" study:
http://www.ilads.org/stricker.htm
'Summary of Klempner's
"study": invalid inclusion/inclusion
criteria, assessments, FIQ not valid,
CDC "Lyme disease" case definition not
valid. Study not
completed. MS hapotype found
and not reported in the "seronegatives"
HLA-DQB1*O602. Some patients never
had ceftriaxone in the first place, and
therefore the "results" did not
confirm the current "standard of care."
Wrong DNA primers were used.
And Klempner
did not culture for more than 3 weeks which is needed to allow the
spheroplast form to start growing again, as
Russell Johnson explains in his article
in the 1989 REVIEWS OF INFECTIOUS DISEASES about culturing.
--2001, July, RI
Diseases of Summer Conference, not disclosing the Haplotype data associated with
Seronegative Lyme:
Klempner DQB1*0602. Compare
to:
http://www.geocities.com/kmdickson0308/1-6.txt
Video IIa,
Mark Klempner discusses his HLA secret (MS and Lyme Disease)
03:03 minutes YouTube
Klempner's Secret Haplotype:
HLA-DQB1*0602
Klempner says: "Chronic Neurologic Lyme could be due
to either LYMErix vaccination (OspA) autoimmunity or antibiotic treatment
failure"
Mark Klempner
says: the IV drug ceftriaxone, which is used for meningitis (and not
knee-only diseases), does not kill all the spirochetes (click here
for full text journal article)
Klempner-read
carefully what he says are the criteria for performing this study in the
first place. This is full text report
It sorta conflicts with what he says in the
IDSA "Guidelines"
More On Mark Klempner's Boston Biowarfare Lab. Think
about it: Mark got promoted by the CDC for lying in the journals and to the
public about "Lyme disease."
That's a pretty good endorsement of my claims that he committed research
FRAUD, right? Being promoted by the CDC? It's like Kevin J. O'Connor, the
Corrupticut "US Attorney," who was promoted by Constitution
Gonzo, while all the good US Attorneys were axed.
--2001
Klempner at the Rare Diseases Conference
with the DQB1*0602 data:
http://rarediseases.info.nih.gov/news-reports/workshops/humanneuro20010909.html
Lyme is clinically indistinguishable
from MS.
See Roland Martin, Cellular Immunology
Section, NINDS
See
also: Lyme and MS: NIH CLINICAL
TRIALS
MS and "Lyme disease" (the
CDC/Dearborn/LYMErix disease kind)
--2002, January,
New neoplasms
from rOspA not reported to WHO by Yale.
: Abstract, MEDLINE
Full
text: LymeRIX_Phase_4_and_breast_cancer
--Why
the lawsuits against The Yale
Corporation, Glaxo-SmithKline, Aventis,
The State of New Jersey, the State of
Connecticut, the State of New York, L2
Diagnostics, Possibly Mayo (Persing),
Corixa (Persing), Imugen (Molloy and
possibly Steere), New York Biotech http://www.nyba.org, ALDF.com Board
of Directors, and CastleConnolly.com are
winnable:
Here
GEN*NY*SIS (Kemp Hannon), New York State
Employees Profile:
http://www.osc.state.ny.us/press/releases/apr03/rpt304.pdf